A. Baalbergen

发表

Prognostic factors in adenocarcinoma of the uterine cervix.

W. Hop, P. Ewing-Graham, P. Struijk, 2004, Gynecologic oncology.

Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands

J. Piek, I. Schoots, W. V. van Driel, 2022, Annals of Surgical Oncology.

Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.

A. Ansink, A. Baalbergen, Y. Veenstra, 2010, The Cochrane database of systematic reviews.

Conservative Therapy in Microinvasive Adenocarcinoma of the Uterine Cervix is Justified: An Analysis of 59 Cases and a Review of the Literature

F. Smedts, T. Helmerhorst, A. Baalbergen, 2011, International Journal of Gynecologic Cancer.

Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri

F. Smedts, W. Quint, A. Molijn, 2015, Journal of lower genital tract disease.

Adenocarcinoma in Situ of the Uterine Cervix—A Systematic Review

T. Helmerhorst, A. Baalbergen, 2014, International Journal of Gynecologic Cancer.

Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.

R. Steenbergen, P. Snijders, T. Helmerhorst, 2011, Gynecologic oncology.

CA‐125 Levels are Related to the Likelihood of Pregnancy After In Vitro Fertilization and Embryo Transfer

R. V. D. van der Weiden, A. Baalbergen, J. W. Janssen, 2000, American journal of reproductive immunology.

Prognostic factors that predict survival after relapse of cervical cancer

C. Burger, T. Helmerhorst, A. Baalbergen, 2001 .

Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands

J. Piek, I. Schoots, W. V. van Driel, 2022, Annals of Surgical Oncology.

Prognosis of adenocarcinoma of the uterine cervix: p53 expression correlates with higher incidence of mortality

M. Eijkemans, P. Ewing-Graham, T. Helmerhorst, 2007, International journal of cancer.

Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue.

C. V. van Asperen, T. van Wezel, T. Bosse, 2018, The Journal of molecular diagnostics : JMD.

High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.

F. Smedts, W. Quint, P. Snijders, 2011, Gynecologic oncology.

The prediction of progression‐free and overall survival in women with an advanced stage of epithelial ovarian carcinoma

D. de Jong, M J C Eijkemans, A C Ansink, 2009, BJOG : an international journal of obstetrics and gynaecology.

Preoperative Predictors for Residual Tumor after Surgery in Patients with Ovarian Carcinoma

D. de Jong, M. Eijkemans, C. Gerestein, 2008, Oncology.

Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.

A. Baalbergen, Y. Veenstra, L. Stalpers, 2013, The Cochrane database of systematic reviews.

HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix.

F. Smedts, C. Meijer, P. Snijders, 2013, Gynecologic oncology.

Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands

G. N. Boer, J. Piek, I. Schoots, 2019, BMC Cancer.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

J. Klijn, H. Meijers-Heijboer, C. Seynaeve, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

W. van Driel, K. Overmars, D. Boll, 2022, Gynecologic Oncology.

Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands.

M. van der Aa, C. Gerestein, P. Zusterzeel, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.

B. V. van Munster, F. Amant, A. Viddeleer, 2021, Gynecologic oncology.

ASO Visual Abstract: The Role of Adjuvant Use of the PlasmaJet® Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer—Results of the PlaComOv-Study, a Randomized, Controlled Trial in the Netherlands

I. Schoots, P. Ewing-Graham, I. Boere, 2022, Annals of Surgical Oncology.

Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications.

B. V. van Munster, F. Amant, A. Viddeleer, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adenocarcinoma of the Uterine Cervix and its Precursor Lesion

A. Baalbergen, 2014 .